Exercise can effectively ameliorate type 2 diabetes and insulin resistance. Here we show that the mRNA levels of one of peroxisome proliferatoractivated receptor (PPAR) family members, PPAR␥1, and genes related to energy metabolism, including PPAR␥ coactivator-1 protein-1␣ (PGC-1␣) and lipoprotein lipase (LPL), increased in the gastrocnemius muscle of habitual exercise-trained mice. When mice were intraperitoneally administered an AMP-activated protein kinase (AMPK) activator 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR), the mRNA levels of the aforementioned three genes increased in gastrocnemius muscle. AICAR treatment to C2C12 differentiated myotubes also increased PPAR␥1 mRNA levels, but not PPAR␣ and -␦ mRNA levels, concomitant with increased PGC-1␣ mRNA levels. An AMPK inhibitor, compound C, blocked these AICAR effects. AICAR treatment increased the half-life of PPAR␥1 mRNA nearly threefold (4 -12 h) by activating AMPK. When C 2C12 myoblast cells infected with a PPAR␥1 expression lentivirus were differentiated into myotubes, PPAR␥1 overexpression dramatically increased LPL mRNA levels more than 40-fold. In contrast, when PPAR␥1 expression was suppressed in C2C12 myotubes, LPL mRNA levels were significantly reduced, and the effect of AICAR on increased LPL gene expression was almost completely blocked. These results indicated that PPAR␥1 was intimately involved in LPL gene expression in skeletal muscle and the AMPK-PPAR␥1 pathway may play a role in exercise-induced LPL expression. Thus, we identified a novel critical role for PPAR␥1 in response to AMPK activation for controlling the expression of a subset of genes associated with metabolic regulation in skeletal muscle.
PHYSICAL EXERCISE HAS BENEFICIAL EFFECTS on general health and results in increased catabolism of glucose and fatty acids as energy sources in skeletal muscle. AMPK and its related cellular signaling pathways are thought to play a critical role in exercise-mediated adaptations in the muscle (19) . AMPK is an evolutionarily conserved heterotrimer that consists of ␣-catalytic and ␤-and ␥-regulatory subunits and is a regulator of energy homeostasis. AMPK is activated by an increased AMP: ATP ratio associated with ATP consumption during exercise (3, 30) . Activated AMPK drives several energy production systems, including glucose uptake, fatty acid oxidation, and mitochondria biogenesis, to maintain energy balance. Because of these beneficial activities, AMPK is considered to be a target for preventing type 2 diabetes.
The capacity of muscle to catabolize fatty acids is determined at the transcriptional level for genes involved in fatty acid uptake and catabolism. PPAR␣ and -␦, members of the nuclear receptor superfamily, control the transcription of these genes in the muscle (32) . PPAR␣ induces the expression of genes involved in the numerous steps of fatty acid uptake and oxidation in muscle; these genes are shared with PPAR␦ (5) . PPAR␦ associates with an AMPK ␣-subunit and increases basal and ligand-dependent transcription (16) , which suggests that the AMPK-PPAR␦ pathway may play a critical role in regulating the expressions of numerous genes mediated by exercise.
The function of another family member of this family, PPAR␥, as a receptor in skeletal muscle remains unclear due to its much lower level of expression compared with that in adipose tissues. However, it has been reported that physical exercise induced increased PPAR␥ expression in human skeletal muscle through increased reactive oxygen species (ROS) production and that this effect was blocked by antioxidant supplementation (21) .
Skeletal muscle is one of the main biosynthetic tissues of LPL, which hydrolyzes triglycerides contained in chylomicrons and VLDL to yield fatty acids for localized uptake by this tissue. The importance of muscle LPL for removing serum triglycerides was determined by analyzing muscle-specific LPL-deficient mice (28) . These mice exhibited insulin resistance in the liver and adipose tissues and aggravated dietinduced obesity. In addition, a recent study showed that muscle LPL expression in insulin-resistant offspring was lower than that in controls, which indicated that reduced muscle LPL may cause diabetes (15) . The results of these reports suggest a relationship between muscle LPL expression and diabetes although the molecular details of muscle LPL expression mechanisms have not been thoroughly investigated.
To date, a few reports have shown that AMPK regulated LPL expression in cultured skeletal muscle cell lines (17, 18) . These findings were consistent with the observation that exercise training induced increased muscle LPL expression (23) . However, the mechanism by which AMPK increases LPL expression in skeletal muscle remains unclear. In this study, we show that AMPK induces increased expression of a nuclear receptor PPAR␥1 and that this nuclear receptor is a key regulator of LPL expression in C 2 C 12 myotubes. Thus, we have identified a new role for the AMPK-PPAR␥1 pathway in regulating muscle LPL expression that was induced in response to exercise.
MATERIALS AND METHODS
Cell culture. C2C12 myoblast cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 g/ml streptomycin under 5% CO 2 atmosphere. Confluent myoblast cells differentiated into myotubes when cultured in a differentiation medium (2% horse serum, 100 U/ml penicillin, and 100 g/ml streptomycin in DMEM) for 4 -6 days.
Western blot. Protein expression and phosphorylation were analyzed by Western blotting. C 2C12 myotubes and mouse skeletal muscle were lysed with RIPA buffer (50 mM Tris·HCl, pH 7.4, 1 mM EDTA, 150 mM NaCl, 1% Nonidet P-40, and 0.25% sodium deoxycholate) supplemented with a protease inhibitor cocktail (Nacalai Tesque, Kyoto, Japan) and a phosphatase inhibitor cocktail (SigmaAldrich, St. Louis, MO). Equal amounts of protein (10 g/lane) from mixed cell lysates (n ϭ 3) were subjected to SDS-PAGE (8% gel) and transferred to a polyvinylidene difluoride membrane (Millipore, Billerica, MA). Membranes were probed with either an anti-phospho-AMPK␣ (Thr 172 ; Cell Signaling Technology, Beverly, MA), an anti-AMPK␣ (Cell Signaling Technology), an anti-PPAR␥ (Santa Cruz Biotechnology, Santa Cruz, CA), or an anti-␤-actin (Sigma-Aldrich) antibody. Subsequently, membranes were exposed to a horseradish peroxidase-coupled secondary antibody, either an anti-mouse (Jackson Immune Research, West Grove, PA) or an anti-rabbit (Jackson immune research) antibody, and then developed using a chemiluminescence-based detection system (Amersham ECL; GE Healthcare, Pittsburgh, PA).
Real-time quantitative PCR. Total RNA was extracted from C 2C12 myotubes or mouse skeletal muscle using ISOGEN (Nippon Gene, Tokyo, Japan) according to the manufacturer's instructions (25) . RNA was reverse transcribed using a High Capacity cDNA Reverse Transcription kit (Applied Biosystems). Real-time quantitative PCR (Taqman probe and SYBR green) analysis was performed on StepOnePlus Real-Time PCR Systems (Applied Biosystems). The PCR primers used for measuring mRNA were as follows (forward and reverse): for PPAR␣, 5=-CTCGCGTGTGATAAAGC-3= and 5=-CGATGCTGTC-CTCCTTG-3=; PPAR␦, 5=-GCCTCGGGCTTCCACTAC-3= and 5=-AGATCCGATCGCACTTCTCA-3=; PPAR␥1, 5=-GGACTGTGTGA-CAGACAAGATTTG-3= and 5=-CTGAATATCAGTGGTTCACCGC-3=; PPAR␥2, 5=-CTCTGTTTTATGCTGTTATGGGTGA-3= and 5=-GGTCAACAGGAGAATCTCCCAG-3=; PGC-1␣, 5=-TTCTGG-GTGGATTGAAGTGGTG-3= and 5=-TGTCAGTGCATCAAAT-GAGGGC-3=; LPL, 5=-CTTCTTGATTTACACGGAGGT-3= and 5=-ATGGCATTTCACAAACACTG-3=; CD36, 5=-CTTCCACATTTC-CTACATGCAA-3= and 5=-ATCCAGTTATGGGTTCCACATC-3=; UCP-3, 5=-GAGTCAGGGGCCTGTGGAAA-3= and 5=-GCGTTCAT-GTATCGGGTCTT-3=; MyoD, 5=-GCTTCTATCGCCGCCACTCC-3= and 5=-CGCACATGCTCATCCTCACG-3=; myogenin, 5=-GCATGTA-AGGTGTGTAAGAG-3= and 5=-GCGCAGGATCTCCACTTTAG-3=; myosin heavy chain (MyHC), 5=-TCCAAACCGTCTCTGCACTGTT-3= and 5=-AGCGTACAAAGTGTGGGTGTGT-3=. mRNA expression levels were normalized to 18S ribosomal RNA levels (TaqMan ID: Mm03928990_g1, Applied Biosystems). There were no significant differences in 18S ribosomal RNA levels between treatment conditions.
Mice. All animal experiments were performed in accordance with the guidelines of the Animal Usage Committee of the University of Tokyo or Nara Women's University. Mice were housed with a 12:12-h light-dark cycle and given free access to water and food.
Treadmill exercise training. Male C57BL/6 mice (6 wk old) were divided into an exercise group and a control group (n ϭ 4/group). Mice were acclimated to training on a treadmill that was inclined at 10°(15 m/min for 30 min) for 4 wk (5 times/wk). The mice were anesthetized and euthanized 18 h after the last training, and whole gastrocnemius muscle was rapidly excised, frozen in liquid nitrogen, and stored at Ϫ80°C.
AICAR administration. Male C57B/6J mice (8 wk old) were randomly divided into vehicle (saline) and AICAR (10 mg/ml in saline) treatment groups. The mice were treated for 3 days with either vehicle or AICAR (400 mg/kg/day ip). Gastrocnemius muscle was isolated 6 h after the last injection, frozen, and stored at Ϫ80°C until analyzed.
Expression plasmid construction. A pCSII-EF-3Flag-PPAR␥1 lentiviral plasmid was constructed by inserting a fragment encoding for 3Flag-tagged mouse PPAR␥1 into pCSII-EF-MCS-IRES2-Venus (RIKEN, Saitama, Japan). Lentiviral plasmids for shRNA for mouse PPAR␥ or control were constructed by recombining pCS-RfA-EG (RIKEN) with pENTR4-H1 (RIKEN) inserted by oligonucleotide DNA for shRNA expression. The target sequences were as follows: PPAR␥, 5=-AAAAAGTGCAAGAGATCACAGAGTAT-3= (14); and control (Scramble II Duplex from Dharmacon, Lafayette, CO), 5=-GCGCGCTTTGTAGGATTCG-3=.
Lentivirus infection. HEK-293T cells were transfected with a lentiviral expression plasmid together with a VSV-G and Rev-expressing (pCMV-VSV-G-RSV-Rev) and packaging plasmid (pCAG-HIVgp). After 12 h, the cells were further cultured in fresh medium containing 10 M forskolin. The medium containing lentiviruses was collected A B Fig. 1 . Effects of exercise and AICAR treatment on gene expression in gastrocnemius muscle. A: exercise design was described in MATERIALS AND METHODS. After 4 wk of exercise training, gastrocnemius muscle was removed 18 h after the last exercise and PPAR␣, PPAR␦, PPAR␥1, PGC-1␣, LPL, CD36, and UCP3 mRNA levels were determined by quantitative RT-PCR (n ϭ 4). Relative mRNA levels were determined after normalization to 18S ribosomal RNA levels. Relative mRNA levels in the control were set to 1. Results are means Ϯ SD. *P Ͻ 0.05, **P Ͻ 0.01. Final body weights (in g): 29.0 Ϯ 3.1 for controls and 26.8 Ϯ 0.5 for exercised mice. B: mice were treated with vehicle (saline) or AICAR (200 mg/kg ip) twice a day (at 1000 and 2000) for 3 days (400 mg·kg Ϫ1 ·day Ϫ1 ). Whole gastrocnemius muscle was removed 6 h after the last injection (at 1000 on day 4), and PPAR␣, PPAR␦, PPAR␥1, PGC-1␣, LPL, CD36, and UCP3 mRNA levels were determined by quantitative RT-PCR (n ϭ 5). Relative mRNA levels were determined after normalization to 18S ribosomal RNA levels. Relative mRNA levels in the control were set to 1. Results are means Ϯ SD. *P Ͻ 0.05, **P Ͻ 0.01. and filtered. C2C12 cells were infected with a lentivirus medium supplemented with 10 g/ml polybrene for 24 h. The cells were then replenished with fresh culture medium.
Drugs. AICAR, H 2O2, and GW9662 were purchased from Wako Pure Chemical (Osaka, Japan). Metformin and compound C were obtained from Sigma-Aldrich and Calbiochem (La Jolla, CA) respectively.
RESULTS
Four weeks of exercise or AICAR treatment increased mRNA levels of energy metabolism-related genes in mouse skeletal muscle. To determine whether habitual exercise training affected the expression of genes known to be regulated by metabolic changes in skeletal muscle, gastrocnemius muscle was obtained from male C57BL/6 mice that had been acclimated to training on a treadmill inclined at 10°(15 m/min for 30 min) for 4 wk. Real-time RT-PCR analysis showed that the mRNA levels of energy metabolism-related genes, including PGC-1␣, LPL, and UCP3, were significantly increased in the trained mice compared with those in sedentary mice (Fig. 1A) . There was also an increasing trend of CD36 gene expression (P Ͻ 0.1). Increased gene expression of the PPAR subtype PPAR␥1 but not PPAR␣ or -␦, was found after this training.
Because AMPK in skeletal muscle is activated by exercise, we hypothesized that these responses were partly caused by AMPK activation in response to habitual exercise. Thus, we treated mice by intraperitoneally administering the AMPK activator AICAR (400 mg·kg Ϫ1 ·day Ϫ1 ) for 3.5 days. Real-time RT-PCR analysis showed that the mRNA levels of three genes, those for PPAR␥1, PGC-1␣, and LPL, in gastrocnemius muscle were significantly increased, as was observed in exercisetrained mice (Fig. 1B) . CD36 gene expression was significantly increased, whereas the UCP3 mRNA level was only slightly increased in AICAR-treated mice. These results suggested that AMPK activation accounted, at least in part, for the exercise- A: phosphorylated (P-AMPK) or total AMPK (AMPK) and PPAR␥1 (arrow) protein in AICAR (0 -2 mM for 12 h)-treated C2C12 myotubes were detected by Western blotting (left). Western blotting was carried out using C2C12 myotubes treated with 1 mM AICAR for the indicated period of time (right). A stock AICAR solution (100 mM in distilled water) was added to the medium. Mixed cell lysates (n ϭ 3) were subjected to SDS-PAGE. B: PPAR␣, PPAR␦, PPAR␥1, and PGC-1␣ mRNA levels in AICAR (1 mM)-treated C2C12 myotubes (0 -15 h) were determined by quantitative RT-PCR. Relative mRNA levels were determined after normalization to 18S ribosomal RNA levels.
Relative mRNA levels at time 0 were set to 1. Results are means Ϯ SD (n ϭ 3). C: after incubation with 10 mM compound C (Com. C) for 1 h, C2C12 myotubes were further incubated with or without 1 mM AICAR for 9 h. PPAR␥1 mRNA were determined by quantitative RT-PCR. Relative mRNA levels in the control were set to 1.
Results are means Ϯ SD (n ϭ 3). Statistical comparisons were made by one-way analysis of variance. Different superscript letters indicate that the means are significantly different (P Ͻ 0.01). D: C2C12 myotubes were incubated with AICAR (1 mM), metformin (2 mM), or H2O2 (300 M) in the presence or absence of 10 mM compound C for 12 h, as described in Fig. 2C . Mixed cell lysates (n ϭ 3) were subjected to SDS-PAGE, and proteins were detected by Western blotting.
mediated alterations in the expression of a subset of genes in skeletal muscle, particularly that for PPAR␥1. However, we cannot rule out the possibility that AICAR affected muscle gene expression through its pharmacological actions other than AMPK activation (2, 31) . Activated AMPK induces PPAR␥1 gene expression in C 2 C 12 myotubes. To more directly examine this connection, differentiated C 2 C 12 myotubes were cultured with the AMPK activator AICAR, and changes in gene expression in these cells were analyzed. First, C 2 C 12 cells were cultured with various concentrations of AICAR for 12 h, and their whole cell lysates were subjected to immunoblot (Fig. 2A, left) . Both the phosphorylated AMPK and PPAR␥1 protein levels increased in the presence of more than 0.25 mM AICAR. In the following experiments, cells were cultured with 1 mM AICAR to substantially activate AMPK. AMPK phosphorylation was observed within 3 h after AICAR treatment and for an additional 9 h (Fig. 2A, right) . In response to AICAR treatment, the PPAR␥1 protein level increased concurrently with the appearance of phosphorylated AMPK. Because C 2 C 12 myotubes expressed low levels of PPAR␥2 protein, its bands were barely visible in this immunoblot membrane despite its increased mRNA level in response to AICAR (data not shown). The mRNA level of PPAR␥1, but not those of PPAR␣ and -␦, increased in the presence of AICAR in a time-dependent manner and concurrently with its increased protein level (Fig.  2B) . By comparison, the PGC-1␣ mRNA level increased slowly for more than 9 h after AICAR treatment, which was consistent with previous findings (9) . The effect of AICAR to increase the PPAR␥1 mRNA levels was abolished after adding an AMPK inhibitor, compound C (Fig. 2C) . These results indicated that AMPK activation was involved in increased PPAR␥1 expression in myotubes.
Physical exercise induced increased PPAR␥ expression in human skeletal muscle through increased ROS production, and this effect was blocked by antioxidant supplementation (21) . Because AMPK was activated by increased ROS levels in H 2 O 2 -treated cells (4), we cultured C 2 C 12 myotube cells in the presence of H 2 O 2 for 12 h, and changes in AMPK phosphorylation and PPAR␥1 protein levels were analyzed in the presence or absence of compound C (Fig. 2D) . At the same time, to further confirm the finding that AMPK activation was involved in increased PPAR␥1 expression, myotubes were cultured with another AMPK activator, metformin (2 mM), in the presence or absence of compound C. AICAR treatment increased both phosphorylated AMPK and PPAR␥1 protein levels, whereas such increases were abolished by the addition of compound C (lanes 3 and 4) . Similarly, both metformin and H 2 O 2 increased AMPK phosphorylation and PPAR␥1 protein levels only when the culture medium did not contain compound C (lanes 5-7) . Taken together, these results imply that physical exercise induces increased PPAR␥ expression in skeletal muscle by the actions of AMPK via not only decreased ATP levels but also increased ROS levels.
PPAR␥1 mRNA is stabilized in C 2 C 12 myotubes by AICAR. To determine the mechanism by which AICAR induced increased PPAR␥1 gene expression, we performed luciferase assays using a reporter gene that contained the 5= upstream promoter region (2.0 kb) of the mouse PPAR␥1 gene. This promoter was not activated by AICAR (data not shown). Thus, we next investigated the stability of PPAR␥1 mRNA in C 2 C 12 myotubes in the presence of a transcription inhibitor, actinomycin D. PPAR␥1 mRNA was degraded with a half-life of ϳ4 h, and AICAR prolonged this half-life up to 12 h (Fig. 3A) . When C 2 C 12 myotubes were cultured with AICAR and/or compound C for 9 h, the increased PPAR␥1 mRNA level in the presence of AICAR was notably reduced by treatment with compound C; this suggested that AMPK activation was involved in stabilizing PPAR␥1 mRNA (Fig. 3B) .
PPAR␥1 overexpression dramatically increases LPL gene expression in C 2 C 12 myotubes. Although PPAR␦ has been shown to play a critical role in the transcriptional regulation of skeletal muscle metabolism (5), the precise role of another family member, PPAR␥1, in skeletal muscle remains unclear. To analyze the function of increased PPAR␥1 induced in response to AMPK activation, C 2 C 12 myoblasts were infected with a Flag-tagged PPAR␥1 expression lentivirus and then allowed to differentiate into myotubes (Fig. 4A) . Real-time RT-PCR analysis showed that the LPL mRNA level was dramatically increased by PPAR␥1 overexpression (Ͼ40-fold) without any changes in the mRNA levels of differentiation marker genes, including myoD, myogenin, and myosin heavy A B Fig. 3 . AMPK stabilizes PPAR␥1 mRNA and results in a longer mRNA half-life in C2C12 myotubes. A: C2C12 myotubes were pretreated with 5 g/ml actinomycin D for 30 min and then further cultured with or without 1 mM AICAR for 9 h. The mRNA level at time 0 was set at 100%. Results are means Ϯ SD (n ϭ 3). **P Ͻ 0.01 (vs. control). B: C2C12 myotubes were pretreated with 5 g/ml actinomycin D for 60 min and with 10 M compound C for the last 30 min and then further cultured with 1 mM AICAR for 9 h. The mRNA level at time 0 was set at 100%. Percent remaining PPAR␥1 mRNA is shown. Results are means Ϯ SD (n ϭ 3). Statistical comparisons were made by one-way analysis of variance. Different superscript letters indicate that the means are significantly different. P Ͻ 0.01. chain (Fig. 4B) . CD36 gene expression was also upregulated by PPAR␥1 overexpression, whereas UCP3 and PGC-1␣ mRNA levels remained unaffected. These results indicated that increased PPAR␥1 expression induced by exercise or AICAR treatment ( Figs. 1 and 2) was associated with the transcriptional regulation of skeletal muscle metabolism, particularly LPL gene upregulation.
When C 2 C 12 myotube cells were cultured in the presence of AICAR for 36 h, the PPAR␥1 mRNA and protein levels reached a peak between 12 and 24 h, whereas LPL and CD36 mRNA levels significantly increased only at 36 h after AICAR treatment (Fig. 4C) . This time lag suggested that LPL and CD36 may be downstream targets of PPAR␥1. In addition, increased PGC-1␣ induced by AICAR may have coactivated PPAR␥1, which subsequently induced UCP3 gene expression at 24 and 36 h despite no increase in UCP3 mRNA by PPAR␥1 overexpression alone (Fig. 4A) .
PPAR␥1 knockdown abolishes AICAR-induced changes in gene expression in C 2 C 12 myotubes. To determine the relationship between AICAR-mediated AMPK activation and PPAR␥1 function, PPAR␥1 expression in C 2 C 12 myotubes was suppressed using a lentivirus to express shRNA against PPAR␥1, after which AICAR effects were assessed. The increase in PPAR␥1 protein expression in response to AICAR treatment for 12 h was abolished by shRNA against PPAR␥1 (Fig. 5A) . PPAR␥1 knockdown slightly stimulated phosphorylation of AMPK in the presence or absence of AICAR (Fig.  5A ) through an as yet uncharacterized mechanism without any effects on gene expression of differentiation markers (Fig. 5B) . PPAR␥1 knockdown significantly reduced LPL mRNA levels and abolished the increased LPL mRNA level induced by AICAR (Fig. 5C ). This suggested that PPAR␥1 largely regulated LPL gene expression in myotubes and was strongly associated with the effects of AICAR on LPL gene expression. A similar pattern was observed for UCP3 gene expression regulation, although, PPAR␥1 knockdown only partially reduced UCP3 mRNA levels in the presence or absence of AICAR. In addition, CD36 and PGC-1␣ mRNA levels were not affected by PPAR␥1 knockdown at the specific time point of 36 h after AICAR treatment. Additionally, when endogenous PPAR␥ was inhibited by a PPAR␥1 antagonist, GW9662, a similar pattern of the expressions of LPL, CD36, and UCP3 gene was observed (Fig. 5D ).
DISCUSSION
The PPAR␥ isoform PPAR␥2 is expressed at high levels in adipose tissues and plays a critical role as a master regulator of adipocyte differentiation (26) . A shorter isoform, PPAR␥1, which lacks the 30 amino acid residues at the amino terminus of PPAR␥2, is primarily distributed in the muscle, heart, and liver. Because PPAR␥ expression in muscle is only 5-10% of its expression in adipose tissue, its physiological role in muscle has been underestimated. However, a previous report provided evidence for its crucial role in muscle by showing that deleting PPAR␥ in skeletal muscle caused severe insulin resistance in muscle and that treatment with a PPAR␥ agonist did not increase skeletal muscle insulin sensitivity in these animals (7). Nevertheless, how PPAR␥ expression is regulated in skeletal muscle remains unknown. In this report, we showed that exercise caused an increase in PPAR␥1 mRNA and protein levels in muscle, which likely occurred because AMPK was activated. Consistent with a previous report (12) , we failed to detect increased AMPK phosphorylation in muscle of mice 18 h after exercise or 6 h after AICAR treatment (data not shown). It might have been due to the timing of muscle sampling. In contrast, in C 2 C 12 myotubes, we found that both another AMPK activator, metformin, and H 2 O 2 increased phosphorylated AMPK and PPAR␥1 levels and that compound C canceled out these effects, suggesting the importance of AMPK activation for upregulating their expression (Fig. 2D) . Moreover, AICAR treatment increased the half-life of PPAR␥1 mRNA nearly threefold (4 h-12 h; Fig. 3A ) through AMPK activation. Current evidence suggests that the stability of rapidly degraded mRNA is controlled through the 3=-untranslated region (UTR) containing an AU-rich element (ARE) that consists of an AUUUA pentamer (1). We found that five AUUU(U)A sequences are conserved in the 3=-UTR for human, mouse, and rat PPAR␥1 mRNA (data not shown). One ARE-binding protein, HuR, stabilizes mRNAs that contain AREs in their 3=-UTRs. HuR is phosphorylated by AMPK and then transported to the cytoplasm to facilitate mRNA stability (14) . These findings suggest that AMPK activation contributes to increased PPAR␥1 mRNA and protein levels through the actions of HuR. At the same time, because luciferase assays employing a limited upstream region of the PPAR␥1 gene were carried out in this study, we cannot rule out the possibility that PPAR␥1 mRNA synthesis was also increased by AMPK activation (11) .
Another noteworthy result of the current study was that LPL gene expression in skeletal muscle was predominantly regulated by PPAR␥1. Although another PPAR␥ isoform, PPAR␥2, regulates the transcription of a subset of genes in adipocytes, including aP2, LPL, CD36, UCP1, and adiponectin (8, 27, 29) , the target genes of PPAR␥ in skeletal muscle remain uncertain. Our results in this study showed that in C 2 C 12 myotubes infected with a PPAR␥1 expression lentivirus, only LPL gene expression dramatically increased (Fig. 4B) . In addition, PPAR␥1 knockdown significantly suppressed basal LPL gene expression and blocked an AICAR-mediated increase in LPL mRNA levels (Fig. 5C ). These results provide clear evidence for the importance of PPAR␥1 for regulating LPL expression in skeletal muscle and increasing LPL gene expression by AMPK activation. It seems likely that PPAR␥1 indirectly stimulated LPL gene expression, because the increase in LPL mRNA level was observed 12-24 h after increased PPAR␥1 mRNA in response to AICAR (Fig. 4C) , but the precise mechanism remains uncertain at the moment. In contrast, with regard to UCP3 gene expression, PPAR␥1 that is coactivated with increased PGC-1␣ may partially contribute to an increase in its mRNA level. This is based on our findings that UCP3 mRNA levels increased concomitantly with increased PPAR␥ and PGC-1␣ mRNA levels in the gastrocnemius muscle after physical exercise (Fig. 1A) ; overexpression of only PPAR␥1 had no effect on UCP3 gene expression (Fig.  4B) , and PPAR␥1 knockdown moderately reduced the UCP3 mRNA levels in C 2 C 12 myotubes (Fig. 5C ). Taken together, these results indicate that LPL gene expression is regulated mostly by PPAR␥1, whereas UCP3 gene expression is increased by the combination of PPAR␥1, or unknown transcription factor(s) other than PPAR␥1, and PGC-1␣.
It is well known that exercise induces LPL gene expression in human skeletal muscle (22, 23, 24) . Because LPL secreted by skeletal muscle promotes the catabolism of triglyceriderich, atherogenic lipoproteins, LPL activation is thought to exert beneficial effects for preventing of cardiovascular diseases, type 2 diabetes, and metabolic syndrome. The importance of PPAR␥1 in skeletal muscle has also been observed in muscle-specific PPAR␥-null mice that exhibit severe insulin resistance in muscle (7) . In addition, a previous report shows that muscle-specific LPL overexpression prevents diet-induced obesity (10) . These data suggest the beneficial effect of the AMPK-PPAR␥1-LPL pathway for metabolism. In contrast, another report reveals that LPL overexpression in muscle causes insulin resistance in muscle (6) and supports the proposition that only a moderate increase in LPL secreted by skeletal muscle may contribute to a modest uptake of fatty acids that are an energy source in muscle and increase the catabolism of serum triglyceride-rich lipoproteins to reduce the risk of cardiovascular diseases.
In summary, we have shown that habitual exercise induced enhanced expression of PPAR␥1, PGC-1␣, and LPL genes in the skeletal muscle of trained mice (Fig. 6) . Increased expression of these genes was also observed in both AICAR-treated mice and C 2 C 12 myotubes cultured with a couple of AMPK activators. The effects of these activators were blocked by treating the cells with the AMPK inhibitor compound C, which suggested the importance of AMPK activation for enhanced PPAR␥1 expression. We also found that AICAR increased the half-life of PPAR␥1 mRNA nearly threefold through AMPK activation. PPAR␥1 overexpression in C 2 C 12 myotubes resulted in dramatically increased LPL mRNA levels, whereas suppressing its expression blocked an AICAR-mediated increase in LPL mRNA. These results indicate that PPAR␥1 is intimately involved in LPL gene expression in skeletal muscle and that exercise induces increased LPL gene expression likely due to AMPK activation. Overall, these results provide compelling evidence showing a novel critical role for PPAR␥1 in response to AMPK activation caused by physical exercise for controlling the expression of a subset of genes associated with metabolic regulation in skeletal muscle. 
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